Edition:
United States

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

424.40SEK
17 Aug 2018
Change (% chg)

-2.00kr (-0.47%)
Prev Close
426.40kr
Open
423.00kr
Day's High
437.80kr
Day's Low
421.80kr
Volume
4,273
Avg. Vol
10,659
52-wk High
516.00kr
52-wk Low
290.00kr

Chart for

About

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi... (more)
No analyst recommendations are available for .

Overall

Beta: 0.55
Market Cap(Mil.): kr4,941.77
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

  PROB.ST Industry Sector
P/E (TTM): 142.09 20.64 37.19
EPS (TTM): 2.99 -- --
ROI: 3.62 10.51 59.18
ROE: 3.65 14.35 71.73

BRIEF-Probi Q1 Net Sales Fall To SEK 119.2 Million

* Q1 OPERATING PROFIT SEK 4.4 MILLION VERSUS SEK 48.7 MILLION YEAR AGO

May 02 2018

BRIEF-Probi: Positive Results Of Probi's Probiotic Supplement

* PROBI ENTERS THE BONE HEALTH AREA - A NEW AREA FOR PROBIOTICS

Apr 11 2018

BRIEF-Probi Signs Long-Term Agreement With Cilag

* HAS SIGNED A LONG-TERM AGREEMENT WITH CILAG, A MEMBER OF THE JOHNSON & JOHNSON FAMILY OF COMPANIES FOR THE DEVELOPMENT OF A PROBIOTIC PRODUCT

Mar 22 2018

Earnings vs. Estimates